RNAe in a transgenic growth hormone mouse model shows potential for use in gene therapy

Biotechnol Lett. 2017 Feb;39(2):179-188. doi: 10.1007/s10529-016-2236-7. Epub 2016 Nov 4.

Abstract

Objective: RNAe is a new method that enhances protein expression at the post-transcriptional level. RNAe utility was further explored to improve endogenous protein expression.

Results: Transgenic mice were created by targeting RNAe to growth hormone gene into the C57/BL mouse genome by transposon mediated integration; the mice showed a heavier body weight and longer body length compared with normal mice. RNAe can also be used for gene therapy through the delivery of in vitro transcribed RNA.

Conclusion: This study takes a further step towards applying RNAe in pharmaceutical approaches by transposon-based transgenic mice model construction and the use of in vitro transcribed RNA transfection assay.

Keywords: Growth hormone; Pharmaceutical application; Protein production; RNAe; Transgenic mice.

MeSH terms

  • Animals
  • Cell Line
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Flow Cytometry
  • Genetic Therapy / methods
  • Growth Hormone / genetics*
  • HeLa Cells
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Pregnancy
  • RNA, Long Noncoding / genetics*
  • RNA, Messenger / genetics*

Substances

  • RNA, Long Noncoding
  • RNA, Messenger
  • Growth Hormone